W M Brückl - JoVE Visualize

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Pneumologie (Stuttgart, Germany)|July 11, 2019

[Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids]J H Ficker, W M Brückl

Pneumologie (Stuttgart, Germany)|June 26, 2010

[Current status of erlotinib and gefitinib in palliative therapy for NSCLC--does the EGF-R mutation state have any significance?]W M Brückl, G H Wiest, J H Ficker

Der Internist|February 1, 2017

[Haemoptysis : Intensive care management of pulmonary hemorrhage]J H Ficker, W M Brückl, J Suc, et al.

Pneumologie (Stuttgart, Germany)|October 20, 2007

[Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy]W M Brückl, S Lampert, S Zirlik, et al.

Pneumologie (Stuttgart, Germany)|October 20, 2007

[An approach to individualised therapy of non-small cell lung carcinoma (NSCLC)--relevance of molecular predictive and prognostic factors]S Zirlik, S Lampert, E G Hahn, et al.

Pneumologie (Stuttgart, Germany)|February 15, 2017

[Liquid Biopsy: Detection of Molecular Markers for Treatment Decisions in Lung Cancer]W M Brückl, R M Wirtz, T Bertsch, et al.

Deutsche Medizinische Wochenschrift (1946)|February 25, 2000

[Retroperitoneal desmoid tumor with kidney failure in familial adenomatous polyposis]W M Brückl, A Wein, C Riedel, et al.

Pneumologie (Stuttgart, Germany)|June 13, 2015

[Estrogen Receptors and their Impact for Prognosis and Therapy of Lung Cancer - New Insights to an Underestimated Mechanism]W M Brückl, S E Al-Batran, J H Ficker, et al.

Pneumologie (Stuttgart, Germany)|August 3, 2018

[Rebiopsy for Patients with Lung Cancer - Joint Opinion from both the Endoscopic and Thoracic Oncology Sections of the German Society of Pneumology (DGP)]W M Brückl, J H Ficker, M Tiemann, et al.

Anticancer Research|March 16, 2004

Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC)K Link, K Happich, I Schirner, et al.

Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Pneumologie (Stuttgart, Germany)|July 11, 2019

[Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids]J H Ficker, W M Brückl

Pneumologie (Stuttgart, Germany)|June 26, 2010

[Current status of erlotinib and gefitinib in palliative therapy for NSCLC--does the EGF-R mutation state have any significance?]W M Brückl, G H Wiest, J H Ficker

Der Internist|February 1, 2017

[Haemoptysis : Intensive care management of pulmonary hemorrhage]J H Ficker, W M Brückl, J Suc, et al.

Pneumologie (Stuttgart, Germany)|October 20, 2007

[Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy]W M Brückl, S Lampert, S Zirlik, et al.

Pneumologie (Stuttgart, Germany)|October 20, 2007

[An approach to individualised therapy of non-small cell lung carcinoma (NSCLC)--relevance of molecular predictive and prognostic factors]S Zirlik, S Lampert, E G Hahn, et al.

Pneumologie (Stuttgart, Germany)|February 15, 2017

[Liquid Biopsy: Detection of Molecular Markers for Treatment Decisions in Lung Cancer]W M Brückl, R M Wirtz, T Bertsch, et al.

Deutsche Medizinische Wochenschrift (1946)|February 25, 2000

[Retroperitoneal desmoid tumor with kidney failure in familial adenomatous polyposis]W M Brückl, A Wein, C Riedel, et al.

Pneumologie (Stuttgart, Germany)|June 13, 2015

[Estrogen Receptors and their Impact for Prognosis and Therapy of Lung Cancer - New Insights to an Underestimated Mechanism]W M Brückl, S E Al-Batran, J H Ficker, et al.

Pneumologie (Stuttgart, Germany)|August 3, 2018

[Rebiopsy for Patients with Lung Cancer - Joint Opinion from both the Endoscopic and Thoracic Oncology Sections of the German Society of Pneumology (DGP)]W M Brückl, J H Ficker, M Tiemann, et al.

Anticancer Research|March 16, 2004

Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC)K Link, K Happich, I Schirner, et al.

Pageof 1